Literature DB >> 9754447

The c-Fes family of protein-tyrosine kinases.

T E Smithgall1, J A Rogers, K L Peters, J Li, S D Briggs, J M Lionberger, H Cheng, A Shibata, B Scholtz, S Schreiner, N Dunham.   

Abstract

The human c-fes protooncogene encodes a protein-tyrosine kinase (c-Fes) distinct from c-Src, c-Abl and other nonreceptor tyrosine kinases. Although originally identified as the cellular homolog of several transforming retroviral oncoproteins, Fes was later found to exhibit strong expression in myeloid hematopoietic cells and to play a direct role in their differentiation. Recent work has shown that Fes exhibits a more widespread expression pattern in both developing and adult tissues, suggesting a general physiological function for this kinase and its closely related homolog, Fer. This review highlights the unique aspects of Fes structure, regulation, and function that set it apart from other tyrosine kinase families.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754447     DOI: 10.1615/critrevoncog.v9.i1.40

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  14 in total

1.  The human c-Fes tyrosine kinase binds tubulin and microtubules through separate domains and promotes microtubule assembly.

Authors:  Charles E Laurent; Frank J Delfino; Haiyun Y Cheng; Thomas E Smithgall
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

2.  The KRAB-associated co-repressor KAP-1 is a coiled-coil binding partner, substrate and activator of the c-Fes protein tyrosine kinase.

Authors:  Frank J Delfino; Jonathan M Shaffer; Thomas E Smithgall
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

3.  Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer.

Authors:  Jonathan M Shaffer; Thomas E Smithgall
Journal:  Genes Chromosomes Cancer       Date:  2009-03       Impact factor: 5.006

4.  Fer tyrosine kinase is required for germinal vesicle breakdown and meiosis-I in mouse oocytes.

Authors:  Lynda K McGinnis; Xiaoman Hong; Lane K Christenson; William H Kinsey
Journal:  Mol Reprod Dev       Date:  2011-01       Impact factor: 2.609

5.  A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.

Authors:  H Y Cheng; A P Schiavone; T E Smithgall
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.

Authors:  Shengnan Zhang; Violeta Chitu; E Richard Stanley; Bruce E Elliott; Peter A Greer
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

7.  Bimolecular fluorescence complementation demonstrates that the c-Fes protein-tyrosine kinase forms constitutive oligomers in living cells.

Authors:  Jonathan M Shaffer; Sabine Hellwig; Thomas E Smithgall
Journal:  Biochemistry       Date:  2009-06-09       Impact factor: 3.162

8.  Downregulation of the c-Fes protein-tyrosine kinase inhibits the proliferation of human renal carcinoma cells.

Authors:  Shigeru Kanda; Yasuyoshi Miyata; Hiroshi Kanetake; Thomas E Smithgall
Journal:  Int J Oncol       Date:  2009-01       Impact factor: 5.650

9.  Fer kinase is required for sustained p38 kinase activation and maximal chemotaxis of activated mast cells.

Authors:  Andrew W B Craig; Peter A Greer
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

10.  The nonreceptor tyrosine kinase fer mediates cross-talk between N-cadherin and beta1-integrins.

Authors:  C Arregui; P Pathre; J Lilien; J Balsamo
Journal:  J Cell Biol       Date:  2000-06-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.